STOCKHOLDERS’ EQUITY (Tables)

9 Months Ended

Mar. 31, 2024

Equity [Abstract]

SCHEDULE OF SHARE BASED COMPENSATION

	Three and Nine Months Ended March 31, 2024
Expected volatility		159% - 197	%
Expected term		6.3 years
Risk-Free interest rate		3.5% - 4.7	%
Expected dividend yield		0	%

SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS

	Stock Options
	Number of Options			Weighted Average Exercise Price
Outstanding at July 1, 2023		270,000		$	1.61
Granted		315,881		$	1.15
Forfeited		(38,750	)	$	1.64
Outstanding and expected to vest at March 31, 2024		547,131		$	1.34
Exercisable as of March 31, 2024		72,912		$	1.60

SCHEDULE OF SHARE BASED COMPENSATION RESTRICTED STOCK OUTSTANDING

The following table summarizes the restricted stock activities for the nine months ended March 31, 2024.

	Restricted Stock Awards
	Number of RSAs			Weighted Average Grant Date Fair Value
Nonvested as of July 1, 2023		288,733		$	1.36
Granted		447,543		$	1.03
Canceled		(23,585	)	$	1.06
Vested		(30,124	)	$	1.39
Nonvested as of March 31, 2024		628,567		$	1.15

SCHEDULE OF SHARE BASED PAYMENT ARRANGEMENT

The table below summarizes total remaining stock-based compensation for all outstanding awards (in thousands):

Years Ending June 30,
Remainder of fiscal 2024	$	111
2025		479
2026		351
2027		186
2028		17
Total stock-based compensation	$	1,144